EA202190132A1 -
A PREPARATION FOR SUPPRESSING THE RECURRENCE OF HEMATOLOGICAL MALIGNANT TUMOR IN PATIENTS UNDER HEMOPOETIC STEM CELL TRANSPLANTATION
- Google Patents
A PREPARATION FOR SUPPRESSING THE RECURRENCE OF HEMATOLOGICAL MALIGNANT TUMOR IN PATIENTS UNDER HEMOPOETIC STEM CELL TRANSPLANTATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Прайотера ЛимитедfiledCriticalПрайотера Лимитед
Priority claimed from PCT/JP2019/029524external-prioritypatent/WO2020022507A1/en
Publication of EA202190132A1publicationCriticalpatent/EA202190132A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Фармацевтический препарат, который подавляет рецидив гематологических злокачественных опухолей и/или улучшает показатель выживаемости пациентов, перенесших трансплантацию гемопоэтических стволовых клеток для лечения гематологических злокачественных опухолей, содержащий 2-амино-2-[4-(3-бензилоксифенилтио)-2-хлорфенил]этилпропан-1,3-диол или его фармацевтически приемлемую соль в качестве активного ингредиента.A pharmaceutical preparation that suppresses the recurrence of hematological malignant tumors and / or improves the survival rate of patients undergoing hematopoietic stem cell transplantation for the treatment of hematological malignant tumors, containing 2-amino-2- [4- (3-benzyloxyphenylthio) -2-chlorophenyl] ethylpropane- 1,3-diol or a pharmaceutically acceptable salt thereof as an active ingredient.
EA202190132A2019-02-282019-07-26
A PREPARATION FOR SUPPRESSING THE RECURRENCE OF HEMATOLOGICAL MALIGNANT TUMOR IN PATIENTS UNDER HEMOPOETIC STEM CELL TRANSPLANTATION
EA202190132A1
(en)
kras g12c inhibitory compounds, pharmaceutical composition comprising said compounds, methods for regulating the activity and for preparing a kras, hras or nras g12c mutant protein, method for inhibiting the proliferation of a population of cells and therapeutic uses of said compounds